Other Species / Isoforms
  GTSE1 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
K6-sm
__MDDPKkEDILLLA
0 1
GTSE1 (human) __MDDPKkEDILLLA K6-sm
GTSE1 (mouse) _MDAGSKKEDFLLLE K7
GTSE1 (rat) KMDPGSKKEDFLLLE K26
K6-ub
__MDDPKkEDILLLA
0 1
GTSE1 (human) __MDDPKkEDILLLA K6-ub
GTSE1 (mouse) _MDAGSKKEDFLLLE K7
GTSE1 (rat) KMDPGSKKEDFLLLE K26
S65
EQPPLPTSEsPFAWs
0 1
GTSE1 (human) EQPPLPTSEsPFAWs S65
GTSE1 (mouse) GQPLAPGsGsPCtLs S66-p
GTSE1 (rat) EQPLAPGSGSPCTWS S85
S67-p
PPLPTSEsPFAWsPL
0 9
GTSE1 (human) PPLPTSEsPFAWsPL S67-p
GTSE1 (mouse) PLAPGsGsPCtLsPL S68-p
GTSE1 (rat) PLAPGSGSPCTWSPL S87
A70
PTSEsPFAWsPLAGE
0 1
GTSE1 (human) PTSEsPFAWsPLAGE A70
GTSE1 (mouse) PGsGsPCtLsPLTGE T71-p
GTSE1 (rat) PGSGSPCTWSPLTGE T90
S72-p
SEsPFAWsPLAGEKF
0 11
GTSE1 (human) SEsPFAWsPLAGEKF S72-p
GTSE1 (mouse) sGsPCtLsPLTGEKF S73-p
GTSE1 (rat) SGSPCTWSPLTGEKF S92
Y83-p
GEKFVEVyKEAHLLA
0 7
GTSE1 (human) GEKFVEVyKEAHLLA Y83-p
GTSE1 (mouse) GEKFVEVYKEAHLLA Y84
GTSE1 (rat) GEKFVEVYKEAHLLA Y103
S95-p
LLALHIEsSSRNQAA
0 1
GTSE1 (human) LLALHIEsSSRNQAA S95-p
GTSE1 (mouse) LLALQIESHSRREVA S96
GTSE1 (rat) LLALQIECHSRREVA C115
K106-ub
NQAAQAAkPEDPRsQ
0 3
GTSE1 (human) NQAAQAAkPEDPRsQ K106-ub
GTSE1 (mouse) REVAQAATPQNPVNQ T107
GTSE1 (rat) REVAQAAKPRSAVSQ K126
S112-p
AkPEDPRsQGVERFI
0 6
GTSE1 (human) AkPEDPRsQGVERFI S112-p
GTSE1 (mouse) ATPQNPVNQGKETFV N113
GTSE1 (rat) AKPRSAVSQAKETFV S132
K123-sm
ERFIQESkLkINLFE
0 1
GTSE1 (human) ERFIQESkLkINLFE K123-sm
GTSE1 (mouse) ETFVQDSQLKVSLFE Q124
GTSE1 (rat) ETFVQDSQLKISLFE Q143
K123-ub
ERFIQESkLkINLFE
0 3
GTSE1 (human) ERFIQESkLkINLFE K123-ub
GTSE1 (mouse) ETFVQDSQLKVSLFE Q124
GTSE1 (rat) ETFVQDSQLKISLFE Q143
K125-ub
FIQESkLkINLFEkE
0 3
GTSE1 (human) FIQESkLkINLFEkE K125-ub
GTSE1 (mouse) FVQDSQLKVSLFEKE K126
GTSE1 (rat) FVQDSQLKISLFEKE K145
K131-ub
LkINLFEkEKEMKKs
0 1
GTSE1 (human) LkINLFEkEKEMKKs K131-ub
GTSE1 (mouse) LKVSLFEKEQKRDRs K132
GTSE1 (rat) LKISLFEKEQKRDKS K151
S138-p
kEKEMKKsPtsLkRE
0 7
GTSE1 (human) kEKEMKKsPtsLkRE S138-p
GTSE1 (mouse) KEQKRDRsPMsLKRE S139-p
GTSE1 (rat) KEQKRDKSPLSLKRE S158
T140-p
KEMKKsPtsLkREty
0 2
GTSE1 (human) KEMKKsPtsLkREty T140-p
GTSE1 (mouse) QKRDRsPMsLKRETF M141
GTSE1 (rat) QKRDKSPLSLKRETF L160
S141-p
EMKKsPtsLkREtyy
Upstream
0 2
Treatment
  • BI2536
GTSE1 (human) EMKKsPtsLkREtyy S141-p
GTSE1 (mouse) KRDRsPMsLKRETFC S142-p
GTSE1 (rat) KRDKSPLSLKRETFC S161
K143-sm
KKsPtsLkREtyyLs
0 1
GTSE1 (human) KKsPtsLkREtyyLs K143-sm
GTSE1 (mouse) DRsPMsLKRETFCLP K144
GTSE1 (rat) DKSPLSLKRETFCLP K163
T146-p
PtsLkREtyyLsDsP
Upstream
0 8
Treatment
  • BI2536
GTSE1 (human) PtsLkREtyyLsDsP T146-p
GTSE1 (mouse) PMsLKRETFCLPSSR T147
GTSE1 (rat) PLSLKRETFCLPSSR T166
Y147-p
tsLkREtyyLsDsPL
0 2
GTSE1 (human) tsLkREtyyLsDsPL Y147-p
GTSE1 (mouse) MsLKRETFCLPSSRV F148
GTSE1 (rat) LSLKRETFCLPSSRA F167
Y148-p
sLkREtyyLsDsPLL
0 1
GTSE1 (human) sLkREtyyLsDsPLL Y148-p
GTSE1 (mouse) sLKRETFCLPSSRVQ C149
GTSE1 (rat) SLKRETFCLPSSRAQ C168
S150-p
kREtyyLsDsPLLGP
0 5
GTSE1 (human) kREtyyLsDsPLLGP S150-p
GTSE1 (mouse) RETFCLPSSRVQPPM S152
GTSE1 (rat) RETFCLPSSRAQPLL S171
S152-p
EtyyLsDsPLLGPPV
Upstream
0 14
Treatment
  • BI2536
  • ischemia
  • nocodazole
GTSE1 (human) EtyyLsDsPLLGPPV S152-p
GTSE1 (mouse) ETFCLPSSRVQPPMG S153
GTSE1 (rat) ETFCLPSSRAQPLLG S172
S167-p
GEPRLLAssPALPSS
0 2
GTSE1 (human) GEPRLLAssPALPSS S167-p
GTSE1 (mouse) GEPQLLASPGLLSSP S167
GTSE1 (rat) GEPQLLASPGLPNSP S186
S168-p
EPRLLAssPALPSSG
Upstream
0 15
Regulatory protein:
  • PLK1 (human)
Treatment
  • nocodazole
GTSE1 (human) EPRLLAssPALPSSG S168-p
GTSE1 (mouse) EPQLLASPGLLSSPV P168
GTSE1 (rat) EPQLLASPGLPNSPL P187
L180
SSGAQARLTrAPGPP
0 1
GTSE1 (human) SSGAQARLTrAPGPP L180
GTSE1 (mouse) VSAGPAQtQsNQGLP T182-p
GTSE1 (rat) LPAGPVQTQSTQGPP T201
R182
GAQARLTRAPGPPHs
0 1
GTSE1 (human) GAQARLTRAPGPPHs R182
GTSE1 (mouse) AGPAQtQsNQGLPCS S184-p
GTSE1 (rat) AGPVQTQSTQGPPCS S203
R182-m1
GAQARLTrAPGPPHs
0 1
GTSE1 (human) GAQARLTrAPGPPHs R182-m1
GTSE1 (mouse) AGPAQtQSNQGLPCS S184
GTSE1 (rat) AGPVQTQSTQGPPCS S203
S189-p
rAPGPPHsAHALPRE
0 5
GTSE1 (human) rAPGPPHsAHALPRE S189-p
GTSE1 (mouse) sNQGLPCSSQPLPRE S191
GTSE1 (rat) STQGPPCSSQPPSQA S210
K215-m1
TQRKPGTkLLLPRAA
0 1
GTSE1 (human) TQRKPGTkLLLPRAA K215-m1
GTSE1 (mouse) PQKRITSKLQPPRAL K217
GTSE1 (rat) PQRRIMSKLQPPRAL K226
S223-p
LLLPRAAsVRGRsIP
Upstream
1 1
Kinase, in vitro:
  • PLK1 (human)
GTSE1 (human) LLLPRAAsVRGRsIP S223-p
GTSE1 (mouse) LQPPRALPVRGRNLH P225
GTSE1 (rat) LQPPRALPVRGRNLF P234
S228-p
AAsVRGRsIPGAAEK
0 4
GTSE1 (human) AAsVRGRsIPGAAEK S228-p
GTSE1 (mouse) ALPVRGRNLHLATEK N230
GTSE1 (rat) ALPVRGRNLFLATEK N239
S243-p
PKKEIPAsPsRTKIP
Upstream
0 26
Treatment
  • nocodazole
GTSE1 (human) PKKEIPAsPsRTKIP S243-p
GTSE1 (mouse) LKKEVPASIQRTKLV S245
GTSE1 (rat) LKKEVPASLQQTKPL S254
S245-p
KEIPAsPsRTKIPAE
Upstream
0 16
Regulatory protein:
  • OGT (human)
GTSE1 (human) KEIPAsPsRTKIPAE S245-p
GTSE1 (mouse) KEVPASIQRTKLVNE Q247
GTSE1 (rat) KEVPASLQQTKPLNE Q256
S276-p
VNVPAAGsHLGQGKR
0 1
GTSE1 (human) VNVPAAGsHLGQGKR S276-p
GTSE1 (mouse) gap -
GTSE1 (rat) gap -
K299-ub
GLKKTLLkAPGstSN
0 1
GTSE1 (human) GLKKTLLkAPGstSN K299-ub
GTSE1 (mouse) GLKKTLLKPPGYTGN K298
GTSE1 (rat) GLKKTLLKPPGYTSN K307
S303-p
TLLkAPGstSNLARk
0 8
GTSE1 (human) TLLkAPGstSNLARk S303-p
GTSE1 (mouse) TLLKPPGYTGNLTRK Y302
GTSE1 (rat) TLLKPPGYTSNLTKK Y311
T304-p
LLkAPGstSNLARks
0 2
GTSE1 (human) LLkAPGstSNLARks T304-p
GTSE1 (mouse) LLKPPGYTGNLTRKS T303
GTSE1 (rat) LLKPPGYTSNLTKKs T312
K310-m1
stSNLARksssGPVW
0 1
GTSE1 (human) stSNLARksssGPVW K310-m1
GTSE1 (mouse) YTGNLTRKSstsGsA K309
GTSE1 (rat) YTSNLTKKsstSGSA K318
S311-p
tSNLARksssGPVWS
0 4
GTSE1 (human) tSNLARksssGPVWS S311-p
GTSE1 (mouse) TGNLTRKSstsGsAS S310
GTSE1 (rat) TSNLTKKsstSGSAS S319-p
S312-p
SNLARksssGPVWSG
0 21
GTSE1 (human) SNLARksssGPVWSG S312-p
GTSE1 (mouse) GNLTRKSstsGsASS S311-p
GTSE1 (rat) SNLTKKsstSGSASS S320-p
-
gap
0 6
GTSE1 (human) gap -
GTSE1 (mouse) NLTRKSstsGsASSL T312-p
GTSE1 (rat) NLTKKsstSGSASSL T321-p
S313-p
NLARksssGPVWSGA
0 5
GTSE1 (human) NLARksssGPVWSGA S313-p
GTSE1 (mouse) LTRKSstsGsASSLE S313-p
GTSE1 (rat) LTKKsstSGSASSLV S322
V316
RksssGPVWSGASsA
0 1
GTSE1 (human) RksssGPVWSGASsA V316
GTSE1 (mouse) RKSstsGsASSLESG S315-p
GTSE1 (rat) KKsstSGSASSLVSG S324
S322-p
PVWSGASsACTsPAV
0 2
GTSE1 (human) PVWSGASsACTsPAV S322-p
GTSE1 (mouse) GsASSLESGVyRSSV S321
GTSE1 (rat) GSASSLVSGVGRSPT S330
C324
WSGASsACTsPAVGk
0 3
GTSE1 (human) WSGASsACTsPAVGk C324
GTSE1 (mouse) SSLESGVyRSSVAGK Y324-p
GTSE1 (rat) SSLVSGVGRSPTAGK G333
S326-p
GASsACTsPAVGkAk
0 7
GTSE1 (human) GASsACTsPAVGkAk S326-p
GTSE1 (mouse) LESGVyRSSVAGKAK S326
GTSE1 (rat) LVSGVGRSPTAGKAK S335
K331-m1
CTsPAVGkAksSEFA
0 1
GTSE1 (human) CTsPAVGkAksSEFA K331-m1
GTSE1 (mouse) yRSSVAGKAKSSEQR K331
GTSE1 (rat) GRSPTAGKAKSSELS K340
K333-ub
sPAVGkAksSEFAsI
0 1
GTSE1 (human) sPAVGkAksSEFAsI K333-ub
GTSE1 (mouse) SSVAGKAKSSEQRSS K333
GTSE1 (rat) SPTAGKAKSSELSSI K342
S334-p
PAVGkAksSEFAsIP
0 1
GTSE1 (human) PAVGkAksSEFAsIP S334-p
GTSE1 (mouse) SVAGKAKSSEQRSSI S334
GTSE1 (rat) PTAGKAKSSELSSIP S343
S339-p
AksSEFAsIPANSsR
0 1
GTSE1 (human) AksSEFAsIPANSsR S339-p
GTSE1 (mouse) KSSEQRSSIPASGSQ S340
GTSE1 (rat) AKSSELSSIPASSSR S348
S345-p
AsIPANSsRPLsNIS
0 1
GTSE1 (human) AsIPANSsRPLsNIS S345-p
GTSE1 (mouse) SSIPASGSQRRTsts S346
GTSE1 (rat) SSIPASSSRRQSVTS S354
S349-p
ANSsRPLsNISkSGR
0 3
GTSE1 (human) ANSsRPLsNISkSGR S349-p
GTSE1 (mouse) ASGSQRRTstsKSGR T350
GTSE1 (rat) ASSSRRQSVTSKLGR S358
N350
NSsRPLsNISkSGRM
0 3
GTSE1 (human) NSsRPLsNISkSGRM N350
GTSE1 (mouse) SGSQRRTstsKSGRI S351-p
GTSE1 (rat) SSSRRQSVTSKLGRV V359
I351
SsRPLsNISkSGRMG
0 1
GTSE1 (human) SsRPLsNISkSGRMG I351
GTSE1 (mouse) GSQRRTstsKSGRIG T352-p
GTSE1 (rat) SSRRQSVTSKLGRVG T360
S352
sRPLsNISkSGRMGP
0 1
GTSE1 (human) sRPLsNISkSGRMGP S352
GTSE1 (mouse) SQRRTstsKSGRIGP S353-p
GTSE1 (rat) SRRQSVTSKLGRVGL S361
K353-ub
RPLsNISkSGRMGPA
0 1
GTSE1 (human) RPLsNISkSGRMGPA K353-ub
GTSE1 (mouse) QRRTstsKSGRIGPA K354
GTSE1 (rat) RRQSVTSKLGRVGLA K362
K379-ub
GASSWQAkRVDVSEL
0 1
GTSE1 (human) GASSWQAkRVDVSEL K379-ub
GTSE1 (mouse) RVFGRQANKADAAQT N380
GTSE1 (rat) RAFCRQAKKADAAQT K388
-
gap
0 1
GTSE1 (human) gap -
GTSE1 (mouse) AEQPKVPtLsPLTQQ T396-p
GTSE1 (rat) AEQPKALTPSPLAQQ T404
S396
EQLTAPPSASPTQPQ
0 3
GTSE1 (human) EQLTAPPSASPTQPQ S396
GTSE1 (mouse) QPKVPtLsPLTQQPQ S398-p
GTSE1 (rat) QPKALTPSPLAQQPQ S406
T404
ASPTQPQTPEGGGQW
0 2
GTSE1 (human) ASPTQPQTPEGGGQW T404
GTSE1 (mouse) PLTQQPQtPEQRGPR T406-p
GTSE1 (rat) PLAQQPQTPKHKGPR T414
S421
SSCAWSESSQLNKTR
0 1
GTSE1 (human) SSCAWSESSQLNKTR S421
GTSE1 (mouse) RLDPDTEtPQLNKTV T420-p
GTSE1 (rat) RVDLDTETCQLNKTV T428
S429-p
SQLNKTRsIRRRDsC
0 6
GTSE1 (human) SQLNKTRsIRRRDsC S429-p
GTSE1 (mouse) PQLNKTVsIKRRDSY S428-p
GTSE1 (rat) CQLNKTVSIKRQDsS S436
S435-p
RsIRRRDsCLNsKTK
Upstream
Downstream
1 30
Effects on Modified Protein
  • intracellular localization
Effects on Biological Processes:
  • cell cycle regulation
Kinase, in vitro:
  • PLK1 (human)
Putative in vivo kinases:
  • PLK1 (human)
Treatment
  • BI2536
  • nocodazole
  • siRNA
GTSE1 (human) RsIRRRDsCLNsKTK S435-p
GTSE1 (mouse) VsIKRRDSYLSCKTE S434
GTSE1 (rat) VSIKRQDsSLGCKTE S442-p
S439-p
RRDsCLNsKTKVMPt
0 2
GTSE1 (human) RRDsCLNsKTKVMPt S439-p
GTSE1 (mouse) RRDSYLSCKTEAVST C438
GTSE1 (rat) RQDsSLGCKTEAVST C446
T446-p
sKTKVMPtPTNQFkI
0 5
GTSE1 (human) sKTKVMPtPTNQFkI T446-p
GTSE1 (mouse) CKTEAVSTTTNPFKV T445
GTSE1 (rat) CKTEAVSTTTNPFKV T453
K452-ub
PtPTNQFkIPkFsIG
0 1
GTSE1 (human) PtPTNQFkIPkFsIG K452-ub
GTSE1 (mouse) STTTNPFKVPQFSVG K451
GTSE1 (rat) STTTNPFKVPQFSVG K459
K455-ub
TNQFkIPkFsIGDsP
0 2
GTSE1 (human) TNQFkIPkFsIGDsP K455-ub
GTSE1 (mouse) TNPFKVPQFSVGEsP Q454
GTSE1 (rat) TNPFKVPQFSVGEsP Q462
S457-p
QFkIPkFsIGDsPDs
Upstream
0 9
Treatment
  • selumetinib
  • vemurafenib
GTSE1 (human) QFkIPkFsIGDsPDs S457-p
GTSE1 (mouse) PFKVPQFSVGEsPGG S456
GTSE1 (rat) PFKVPQFSVGEsPDR S464
S461-p
PkFsIGDsPDsStPK
0 22
GTSE1 (human) PkFsIGDsPDsStPK S461-p
GTSE1 (mouse) PQFSVGEsPGGVtPK S460-p
GTSE1 (rat) PQFSVGEsPDRVTPK S468-p
S464-p
sIGDsPDsStPKLSR
0 3
GTSE1 (human) sIGDsPDsStPKLSR S464-p
GTSE1 (mouse) SVGEsPGGVtPKFSR G463
GTSE1 (rat) SVGEsPDRVTPKISR R471
T466-p
GDsPDsStPKLSRAQ
0 9
GTSE1 (human) GDsPDsStPKLSRAQ T466-p
GTSE1 (mouse) GEsPGGVtPKFSRTH T465-p
GTSE1 (rat) GEsPDRVTPKISRTH T473
S477-p
SRAQRPQsCtsVGRV
Upstream
0 49
Treatment
  • ischemia
GTSE1 (human) SRAQRPQsCtsVGRV S477-p
GTSE1 (mouse) SRTHRLQsWtPASRV S476-p
GTSE1 (rat) SRTHRLQSWTPAGRV S484
T479-p
AQRPQsCtsVGRVtV
0 10
GTSE1 (human) AQRPQsCtsVGRVtV T479-p
GTSE1 (mouse) THRLQsWtPASRVVS T478-p
GTSE1 (rat) THRLQSWTPAGRVVS T486
S480-p
QRPQsCtsVGRVtVH
0 7
GTSE1 (human) QRPQsCtsVGRVtVH S480-p
GTSE1 (mouse) HRLQsWtPASRVVSs P479
GTSE1 (rat) HRLQSWTPAGRVVSS P487
T485-p
CtsVGRVtVHstPVr
0 2
GTSE1 (human) CtsVGRVtVHstPVr T485-p
GTSE1 (mouse) gap -
GTSE1 (rat) gap -
S488-p
VGRVtVHstPVrRss
0 6
GTSE1 (human) VGRVtVHstPVrRss S488-p
GTSE1 (mouse) PASRVVSstPVRRSs S486-p
GTSE1 (rat) PAGRVVSSTPVRRLs S494
T489-p
GRVtVHstPVrRssG
0 22
GTSE1 (human) GRVtVHstPVrRssG T489-p
GTSE1 (mouse) ASRVVSstPVRRSsG T487-p
GTSE1 (rat) AGRVVSSTPVRRLsG T495
R492-m1
tVHstPVrRssGPAP
0 1
GTSE1 (human) tVHstPVrRssGPAP R492-m1
GTSE1 (mouse) VVSstPVRRSsGttP R490
GTSE1 (rat) VVSSTPVRRLsGLTP R498
S494-p
HstPVrRssGPAPQs
Upstream
0 5
Treatment
  • nocodazole
GTSE1 (human) HstPVrRssGPAPQs S494-p
GTSE1 (mouse) SstPVRRSsGttPQG S492
GTSE1 (rat) SSTPVRRLsGLTPQG L500
S495-p
stPVrRssGPAPQsL
Upstream
0 31
Treatment
  • nocodazole
GTSE1 (human) stPVrRssGPAPQsL S495-p
GTSE1 (mouse) stPVRRSsGttPQGL S493-p
GTSE1 (rat) STPVRRLsGLTPQGL S501-p
P497
PVrRssGPAPQsLLs
0 2
GTSE1 (human) PVrRssGPAPQsLLs P497
GTSE1 (mouse) PVRRSsGttPQGLPG T495-p
GTSE1 (rat) PVRRLsGLTPQGLPS L503
A498
VrRssGPAPQsLLsA
0 2
GTSE1 (human) VrRssGPAPQsLLsA A498
GTSE1 (mouse) VRRSsGttPQGLPGs T496-p
GTSE1 (rat) VRRLsGLTPQGLPSS T504
S501-p
ssGPAPQsLLsAWRV
0 2
GTSE1 (human) ssGPAPQsLLsAWRV S501-p
GTSE1 (mouse) SsGttPQGLPGsMRT G499
GTSE1 (rat) LsGLTPQGLPSSMRT G507
-
gap
0 1
GTSE1 (human) gap -
GTSE1 (mouse) tPQGLPGsMRTPLST S503-p
GTSE1 (rat) TPQGLPSSMRTPLST S511
S504-p
PAPQsLLsAWRVsAL
Upstream
0 4
Treatment
  • nocodazole
GTSE1 (human) PAPQsLLsAWRVsAL S504-p
GTSE1 (mouse) GsMRTPLSTRRMsVL S509
GTSE1 (rat) SSMRTPLSTRRMSVL S517
S509-p
LLsAWRVsALPtPAs
Upstream
0 35
Treatment
  • BI2536
  • MLN8054
GTSE1 (human) LLsAWRVsALPtPAs S509-p
GTSE1 (mouse) PLSTRRMsVLPTPAS S514-p
GTSE1 (rat) PLSTRRMSVLPTPAS S522
T513-p
WRVsALPtPAsRRCs
Upstream
0 7
Treatment
  • BI2536
  • nocodazole
GTSE1 (human) WRVsALPtPAsRRCs T513-p
GTSE1 (mouse) RRMsVLPTPASRRLs T518
GTSE1 (rat) RRMSVLPTPASRRLs T526
S516-p
sALPtPAsRRCsGLP
Upstream
0 5
Treatment
  • BI2536
  • nocodazole
GTSE1 (human) sALPtPAsRRCsGLP S516-p
GTSE1 (mouse) sVLPTPASRRLssLP S521
GTSE1 (rat) SVLPTPASRRLsGLP S529
S520-p
tPAsRRCsGLPPMtP
Upstream
0 17
Treatment
  • BI2536
  • nocodazole
GTSE1 (human) tPAsRRCsGLPPMtP S520-p
GTSE1 (mouse) TPASRRLssLPLMAP S525-p
GTSE1 (rat) TPASRRLsGLPLTAP S533-p
G521
PAsRRCsGLPPMtPK
0 4
GTSE1 (human) PAsRRCsGLPPMtPK G521
GTSE1 (mouse) PASRRLssLPLMAPQ S526-p
GTSE1 (rat) PASRRLsGLPLTAPQ G534
T526-p
CsGLPPMtPKtMPRA
Upstream
0 15
Treatment
  • BI2536
  • MLN8054
  • nocodazole
GTSE1 (human) CsGLPPMtPKtMPRA T526-p
GTSE1 (mouse) LssLPLMAPQsMPRA A531
GTSE1 (rat) LsGLPLTAPQSMPRA A539
T529-p
LPPMtPKtMPRAVGs
Upstream
0 8
Treatment
  • BI2536
  • MLN8054
GTSE1 (human) LPPMtPKtMPRAVGs T529-p
GTSE1 (mouse) LPLMAPQsMPRALVs S534-p
GTSE1 (rat) LPLTAPQSMPRALVS S542
S536-p
tMPRAVGsPLCVPAR
Upstream
0 41
Treatment
  • nocodazole
GTSE1 (human) tMPRAVGsPLCVPAR S536-p
GTSE1 (mouse) sMPRALVsPLCVPAR S541-p
GTSE1 (rat) SMPRALVSPLCVPAR S549
S546
CVPARRRSSEPRKNS
0 1
GTSE1 (human) CVPARRRSSEPRKNS S546
GTSE1 (mouse) CVPARRLsSEPRRRS S551-p
GTSE1 (rat) CVPARRLSSEPRRRS S559
S575-p
DSRLVDVsPDRGsPP
0 29
GTSE1 (human) DSRLVDVsPDRGsPP S575-p
GTSE1 (mouse) GGQAQGLSsDESSSP S581
GTSE1 (rat) AGQSQGLSSDESSSP S589
P576
SRLVDVsPDRGsPPs
0 1
GTSE1 (human) SRLVDVsPDRGsPPs P576
GTSE1 (mouse) GQAQGLSsDESSSPP S582-p
GTSE1 (rat) GQSQGLSSDESSSPP S590
S580-p
DVsPDRGsPPsRVPQ
0 20
GTSE1 (human) DVsPDRGsPPsRVPQ S580-p
GTSE1 (mouse) GLSsDESSSPPSSVP S586
GTSE1 (rat) GLSSDESSSPPSSVP S594
S583-p
PDRGsPPsRVPQALN
0 5
GTSE1 (human) PDRGsPPsRVPQALN S583-p
GTSE1 (mouse) DESSSPPSSVPQALN S590
GTSE1 (rat) DESSSPPSSVPQALN S598
S592-p
VPQALNFsPEEsDST
Upstream
0 29
Regulatory protein:
  • PLK1 (human)
GTSE1 (human) VPQALNFsPEEsDST S592-p
GTSE1 (mouse) VPQALNFsPEKSAsP S599-p
GTSE1 (rat) VPQALNFSPEKSDFP S607
S596-p
LNFsPEEsDSTFSKS
0 1
GTSE1 (human) LNFsPEEsDSTFSKS S596-p
GTSE1 (mouse) LNFsPEKSAsPPPQG S603
GTSE1 (rat) LNFSPEKSDFPPSQG S611
S598
FsPEEsDSTFSKSTA
0 1
GTSE1 (human) FsPEEsDSTFSKSTA S598
GTSE1 (mouse) FsPEKSAsPPPQGsS S605-p
GTSE1 (rat) FSPEKSDFPPSQGSS F613
T604
DSTFSKSTATEVARE
0 1
GTSE1 (human) DSTFSKSTATEVARE T604
GTSE1 (mouse) AsPPPQGsSTGAAQG S611-p
GTSE1 (rat) DFPPSQGSSTGTGQG S619
T637
KLEPLAVTPDAASQP
0 3
GTSE1 (human) KLEPLAVTPDAASQP T637
GTSE1 (mouse) KLDQLTItPEAGGRD T656-p
GTSE1 (rat) KLDQLTIAPEAGDRD A664
T656-p
PLIDFCDtPEAHVAV
0 1
GTSE1 (human) PLIDFCDtPEAHVAV T656-p
GTSE1 (mouse) PLIDFSNTPESNTAL T675
GTSE1 (rat) PLIDFSNTPESNMAL T683
T675-p
RPLIDLMtNtPDMNK
0 2
GTSE1 (human) RPLIDLMtNtPDMNK T675-p
GTSE1 (mouse) WPLIDLIMNTPDMGR M694
GTSE1 (rat) WPLIDLIMNTPNMGR M702
T677-p
LIDLMtNtPDMNKNV
Upstream
0 3
Treatment
  • nocodazole
GTSE1 (human) LIDLMtNtPDMNKNV T677-p
GTSE1 (mouse) LIDLIMNTPDMGRND T696
GTSE1 (rat) LIDLIMNTPNMGRSD T704
S688-p
NKNVAKPsPVVGQLI
Upstream
0 4
Treatment
  • erlotinib
GTSE1 (human) NKNVAKPsPVVGQLI S688-p
GTSE1 (mouse) gap -
GTSE1 (rat) gap -
S698-p
VGQLIDLssPLIQLs
Upstream
0 3
Treatment
  • nocodazole
GTSE1 (human) VGQLIDLssPLIQLs S698-p
GTSE1 (mouse) LGQLIDLGsPLIQLs G719
GTSE1 (rat) LGQLIDLGsPLIQLs G727
S699-p
GQLIDLssPLIQLsP
Upstream
0 6
Treatment
  • nocodazole
GTSE1 (human) GQLIDLssPLIQLsP S699-p
GTSE1 (mouse) GQLIDLGsPLIQLsP S720-p
GTSE1 (rat) GQLIDLGsPLIQLsP S728-p
S705-p
ssPLIQLsPEADKEN
Upstream
0 11
Treatment
  • nocodazole
GTSE1 (human) ssPLIQLsPEADKEN S705-p
GTSE1 (mouse) GsPLIQLsPEADKEN S726-p
GTSE1 (rat) GsPLIQLsPEADKEN S734-p
S715-p
ADKENVDsPLLKF__
Upstream
0 9
Treatment
  • nocodazole
GTSE1 (human) ADKENVDsPLLKF__ S715-p
GTSE1 (mouse) ADKENVDsPLLKF__ S736-p
GTSE1 (rat) ADKENVDsPLLKF__ S744-p